April 28th 2025

By Ailsa Colquhoun

Mounjaro KwikPen warning

AAH has warned against grey trading of Mounjaro KwikPen after significant numbers of packs have been shipped outside of the UK. Mounjaro is not licensed for use outside the UK.

AAH states that this practice adversely affects its ability to meet the demand within the UK market. This raises patient safety concerns, and constitutes a clear breach of Lilly terms and conditions for sale.

The DDA fully supports AAH's and Lilly's position regarding grey trading.

AAH customers are reminded that breach of these terms will result in immediate action from Lilly, including restricting supply through this route to prevent further occurrences.

DDA news Supply Shortages

Latest news

DDA raises rural GP issues in Westminster event

DDA Board Member Dr Ian Hume raised the rural challenges facing dispensing GPs in a Rebuild General Practice campaign roundtable with Liberal Democrat MPs.The discussion focused on the challenges facing GP practices across the country, from rising de

MSN: lansoprazole 15mg and 30mg orodispersible tablets

DHSC has published a Tier 2 Medicine Supply Notification (MSN) for lansoprazole 15mg and 30mg orodispersible tablets: limited supply until early January 2027. Up-to-date information abour medicine supply issues can be found in the DHSC and NHSE

England & Wales: August price redetermination

The Department of Health and Social Care has confirmed that the reimbursement price for the following products in the table have been redetermined. This is to reflect an increase in the NHS list price. Generic name Brand name Pack size Ne

View all news

DDA Suppliers Directory

Follow us

ad1

Dispensing Doctors' Association

Follow us

ad1

DDA Best Practice Group

Follow us

ad1

Dispensing Doctors' Association

Follow @TheDDA1 on X